Potent imidazopyridine-based inhibitors of fatty acid synthase (FASN) are described. The compounds are shown to have antiviral (HCV replicon) activities that track with their biochemical activities. The most potent analogue (compound 19) also inhibits rat FASN and inhibits de novo palmitate synthesis in vitro (cell-based) as well as in vivo.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027139 | PMC |
| http://dx.doi.org/10.1021/ml300335r | DOI Listing |
Publication Analysis
Top Keywords
fatty acid
8
acid synthase
8
imidazopyridine-based fatty
4
synthase inhibitors
4
inhibitors anti-hcv
4
anti-hcv activity
4
activity vivo
4
vivo target
4
target modulation
4
modulation potent
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!